Standard
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma. / Braendstrup, P; Langkilde, Annika; Schreiber, K; Ravnborg, M; Sellebjerg, F; Vindeløv, L.
I:
Case Reports in Neurology, Bind 4, Nr. 2, 2012, s. 101-6.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Braendstrup, P
, Langkilde, A, Schreiber, K, Ravnborg, M
, Sellebjerg, F & Vindeløv, L 2012, '
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma',
Case Reports in Neurology, bind 4, nr. 2, s. 101-6.
https://doi.org/10.1159/000339738APA
Braendstrup, P.
, Langkilde, A., Schreiber, K., Ravnborg, M.
, Sellebjerg, F., & Vindeløv, L. (2012).
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.
Case Reports in Neurology,
4(2), 101-6.
https://doi.org/10.1159/000339738Vancouver
Braendstrup P
, Langkilde A, Schreiber K, Ravnborg M
, Sellebjerg F, Vindeløv L.
Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.
Case Reports in Neurology. 2012;4(2):101-6.
https://doi.org/10.1159/000339738Author
Braendstrup, P ; Langkilde, Annika ; Schreiber, K ; Ravnborg, M ; Sellebjerg, F ; Vindeløv, L. / Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma. I: Case Reports in Neurology. 2012 ; Bind 4, Nr. 2. s. 101-6.
Bibtex
@article{5b55639e8d404509b12aca86b3dcbe76,
title = "Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma",
abstract = "Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as treatment for multiple sclerosis (MS) and other autoimmune diseases.",
author = "P Braendstrup and Annika Langkilde and K Schreiber and M Ravnborg and F Sellebjerg and L Vindel{\o}v",
year = "2012",
doi = "10.1159/000339738",
language = "English",
volume = "4",
pages = "101--6",
journal = "Case Reports in Neurology",
issn = "1662-680X",
publisher = "S Karger AG",
number = "2",
}
RIS
TY - JOUR
T1 - Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma
AU - Braendstrup, P
AU - Langkilde, Annika
AU - Schreiber, K
AU - Ravnborg, M
AU - Sellebjerg, F
AU - Vindeløv, L
PY - 2012
Y1 - 2012
N2 - Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as treatment for multiple sclerosis (MS) and other autoimmune diseases.
AB - Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as treatment for multiple sclerosis (MS) and other autoimmune diseases.
U2 - 10.1159/000339738
DO - 10.1159/000339738
M3 - Journal article
C2 - 22740825
VL - 4
SP - 101
EP - 106
JO - Case Reports in Neurology
JF - Case Reports in Neurology
SN - 1662-680X
IS - 2
ER -
